BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24265111)

  • 1. Interaction of the bioactive flavonol, icariin, with the essential human solute carrier transporters.
    Li Z; Cheung FS; Zheng J; Chan T; Zhu L; Zhou F
    J Biochem Mol Toxicol; 2014 Feb; 28(2):91-7. PubMed ID: 24265111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of the bioactive components isolated from Scutellaria baicalensis on the cellular uptake mediated by the essential solute carrier transporters.
    Xu F; Li Z; Zheng J; Gee Cheung FS; Chan T; Zhu L; Zhuge H; Zhou F
    J Pharm Sci; 2013 Nov; 102(11):4205-11. PubMed ID: 24018852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the active components of Punica granatum (pomegranate) with the essential renal and hepatic human Solute Carrier transporters.
    Li Z; Wang K; Zheng J; Cheung FS; Chan T; Zhu L; Zhou F
    Pharm Biol; 2014 Dec; 52(12):1510-7. PubMed ID: 25026340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
    Bachmakov I; Glaeser H; Fromm MF; König J
    Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cells.
    Taub ME; Mease K; Sane RS; Watson CA; Chen L; Ellens H; Hirakawa B; Reyner EL; Jani M; Lee CA
    Drug Metab Dispos; 2011 Nov; 39(11):2093-102. PubMed ID: 21849517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effects of camptothecin (CPT) and its derivatives on the substrate uptakes mediated by human solute carrier transporters (SLCs).
    Zheng J; Chan T; Zhu L; Yan X; Cao Z; Wang Y; Zhou F
    Xenobiotica; 2016 Sep; 46(9):831-40. PubMed ID: 26744836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J; Müller F; Mieth M; Fromm MF; König J
    Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatic uptake transporters by flavonoids.
    Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
    Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of five alkaloids on the substrate transport mediated through human organic anion and cation transporters.
    Shams T; Lu X; Zhu L; Zhou F
    Xenobiotica; 2018 Feb; 48(2):197-205. PubMed ID: 28093031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCP.
    König J; Klatt S; Dilger K; Fromm MF
    Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):81-6. PubMed ID: 22333292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The altered renal and hepatic expression of solute carrier transporters (SLCs) in type 1 diabetic mice.
    Xu C; Zhu L; Chan T; Lu X; Shen W; Gillies MC; Zhou F
    PLoS One; 2015; 10(3):e0120760. PubMed ID: 25789863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
    Kunze A; Huwyler J; Camenisch G; Poller B
    Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of crizotinib and gefitinib with organic anion-transporting polypeptides (OATP)1B1, OATP1B3 and OATP2B1: gefitinib shows contradictory interaction with OATP1B3.
    Sato T; Ito H; Hirata A; Abe T; Mano N; Yamaguchi H
    Xenobiotica; 2018 Jan; 48(1):73-78. PubMed ID: 28005438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models.
    Lu X; Chan T; Zhu L; Bao X; Velkov T; Zhou QT; Li J; Chan HK; Zhou F
    Eur J Pharm Sci; 2018 Mar; 115():132-143. PubMed ID: 29307856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid hormones specifically modify the activity of organic anion transporting polypeptides.
    Koenen A; Köck K; Keiser M; Siegmund W; Kroemer HK; Grube M
    Eur J Pharm Sci; 2012 Nov; 47(4):774-80. PubMed ID: 22982504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters.
    Durmus S; Naik J; Buil L; Wagenaar E; van Tellingen O; Schinkel AH
    Int J Cancer; 2014 Oct; 135(7):1700-10. PubMed ID: 24554572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition.
    Zhou F; Zhu L; Wang K; Murray M
    Adv Drug Deliv Rev; 2017 Jul; 116():21-36. PubMed ID: 27320645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
    Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
    Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.